Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

PRISTINA, Sept 11 (Reuters) - A new minister in Albania charged to handle public procurement will be impervious to bribes, threats, or attempts to curry favour. That is because Diella, as she is ...

Replimune (NASDAQ:REPL) climbed more than 100% on Wednesday as Cantor Fitzgerald upgraded the cancer drug developer, citing a potential reversal of an FDA decision that rejected its lead drug ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Despite a sharp drop in the previous session following the FDA rejection of its skin cancer drug RP1, Replimune (NASDAQ:REPL) shares bounced back on Wednesday even as multiple Wall Street analysts ...

NEW YORK--(BUSINESS WIRE)--Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Replimune Group, Inc. (NASDAQ: REPL) for potential violations of the federal ...

Replimune Group, Inc. (NASDAQ:REPL) stock plunged on Tuesday after a U.S. Food and Drug Administration (FDA) update. The clinical stage biotechnology company received an FDA Complete Response Letter ...

Multiple analysts have issued price targets for $REPL recently. We have seen 4 analysts offer price targets for $REPL in the last 6 months, with a median target of ...

An X user is threatening to sue the company after Elon Musk’s AI-powered chatbot Grok wrote graphic rape fantasies about him in multiple public posts on the social media platform. Responding to ...

Federal prosecutors ripped down hundreds of artificial intelligence-generated phony social media accounts used by Russian operatives to create a "bot farm" that spread lies and pro-Vladimir Putin ...

Spoilers are no fun to deal with. When you want something to remain a surprise, it’s a pain in the rear to have that thing spoiled for you. Social media outlets like Twitter, Facebook, and Reddit have ...